Author

Aniko Rendek

John Radcliffe Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andy Protheroe· 1 shared David Robert MoleiD· 1 shared Edward DrydaleiD· 1 shared Emmanuel Bugarín-EstradaiD· 1 shared Felicia Tucci· 1 shared Giulia Gardumi· 1 shared Hubert SlawinskiiD· 1 shared James M. BancroftiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andy Protheroe

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hallmarks of adaptive immunity in a metastatic clear cell renal cell carcinoma (ccRCC) long-term elite survivor

Felicia Tucci, Edward Drydale, James M. Bancroft, Sakina Amin, Jane I. Pernes, Giulia Gardumi, Tinashe Kanyowa, Maria Lima, Nadia Nasreddin, Olivia Lombardi, Simon John Leedham, Aniko Rendek, Lisa Browning, Emmanuel Bugarín-Estrada, Ruddy Montandon, , Rachael J. M. Bashford-Rogers

This study identifies clonal persistence, tertiary lymphoid structures (TLS) engagement, and coordinated B-T cell immune surveillance as hallmarks of durable tumour control in a long-term survivor of metastatic ccRCC.

bioRxiv · Dec 22, 2025 · PreprintCancer Biology